AllovirInc Stock Analysis

ALVR Stock  USD 4.21  0.01  0.24%   
The small fall in market price for the last few months could raise concerns from retail investors as the firm is trading at a share price of 4.21 on 311,931 in volume. The company executives did not add much value to AllovirInc investors in February. However, diversifying your holdings with AllovirInc or similar stocks can still protect your portfolio during high-volatility market scenarios. The stock standard deviation of daily returns for 90 days investing horizon is currently 5.15. The very high volatility is mostly attributed to the latest market swings and not very good earnings reports from some of the AllovirInc partners.
Check out Trending Equities. To learn how to invest in AllovirInc Stock please use our How to Invest in AllovirInc guide.
The main objective of AllovirInc stock analysis is to determine its intrinsic value, which is an estimate of what AllovirInc is worth, separate from its market price. There are two main types of AllovirInc's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect AllovirInc's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of AllovirInc's stock to identify patterns and trends that may indicate its future price movements.
The AllovirInc stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. AllovirInc is usually not traded on Thanksgiving Day, Christmas Day, Christmas Day ( substitute day ), New Year 's Monday, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. AllovirInc Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and AllovirInc's ongoing operational relationships across important fundamental and technical indicators.

AllovirInc Stock Analysis Notes

About 50.0% of the company shares are held by company insiders. The book value of AllovirInc was presently reported as 2.47. The company recorded a loss per share of 1.97. AllovirInc had not issued any dividends in recent years. The entity had 1:10 split on the April 2, 2013. Allovir, Inc., a clinical-stage cell therapy company, engages in the research and development of allogeneic, off-the-shelf multi-virus specific T cell therapies to prevent and treat devastating viral-associated diseases. Allovir, Inc. was founded in 2013 and is based in Waltham, Massachusetts. Allovir operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 107 people. For more info on AllovirInc please contact Assaf Katan at 617 433 2605 or go to

AllovirInc Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. AllovirInc's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding AllovirInc or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
AllovirInc generated a negative expected return over the last 90 days
AllovirInc has high historical volatility and very poor performance
Net Loss for the year was (168.71 M) with profit before overhead, payroll, taxes, and interest of 165 K.
AllovirInc currently holds about 172.67 M in cash with (142.05 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.91.
AllovirInc has a frail financial position based on the latest SEC disclosures
Roughly 50.0% of the company shares are held by company insiders
Latest headline from DelveInsight Evaluates a Robust Adenovirus Infections Pipeline as 5 Influential Pharma Players to Set Foot in the Domain -

AllovirInc Upcoming and Recent Events

Earnings reports are used by AllovirInc to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to AllovirInc previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
4th of May 2023
Upcoming Quarterly Report
3rd of August 2023
Next Financial Report
31st of March 2023
Next Fiscal Quarter End
21st of February 2024
Next Fiscal Year End
31st of December 2022
Last Quarter Report
31st of December 2022
Last Financial Announcement

AllovirInc Largest EPS Surprises

Earnings surprises can significantly impact AllovirInc's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Fiscal Date
Estimated EPS
Reported EPS
View All Earnings Estimates
View All Earnings Estimates

AllovirInc SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. AllovirInc prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that AllovirInc investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial AllovirInc specific information freely available to individual and institutional investors to make a timely investment decision.
23rd of February 2023
Financial Statements and Exhibits. Regulation FD Disclosure. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
15th of February 2023
Financial Statements and Exhibits. Regulation FD Disclosure. Results of Operations and Financial Condition
9th of February 2023
Unclassified Corporate Event
9th of January 2023
Financial Statements and Exhibits. Regulation FD Disclosure. Results of Operations and Financial Condition
21st of November 2022
Financial Statements and Exhibits. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
3rd of November 2022
Financial Statements and Exhibits. Results of Operations and Financial Condition
5th of August 2022
Unclassified Corporate Event. Unclassified Corporate Event
4th of August 2022
Financial Statements and Exhibits. Results of Operations and Financial Condition

AllovirInc Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as AllovirInc is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading AllovirInc backward and forwards among themselves. AllovirInc's institutional investor refers to the entity that pools money to purchase AllovirInc's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Last TransactionTypeSharesValue
Fmr Llc2022-12-31Common SharesM36.1 M
Artal Group Sa2022-12-31Common Shares5.6 M28.6 M
Alkeon Capital Management Llc2022-12-31Common Shares4.6 M23.6 M
Vanguard Group Inc2022-12-31Common SharesM15.1 M
Blackrock Inc2022-12-31Common Shares2.8 M14.5 M
Gmt Capital Corp2022-12-31Common Shares2.8 M14.2 M
Redmile Group Llc2022-12-31Common Shares1.9 M9.8 M
Ra Capital Management Lp2022-03-31Common Shares1.4 M9.7 M
American International Group Inc2022-12-31Common Shares1.1 M5.9 M
Woodline Partners Lp2022-12-31Common Shares1.1 M5.6 M
Massachusetts Financial Services Co2022-12-31Common Shares980.7 KM
Note, although AllovirInc's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

AllovirInc Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 381.33 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate AllovirInc's market, we take the total number of its shares issued and multiply it by AllovirInc's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

AllovirInc Profitablity

AllovirInc's profitability indicators refer to fundamental financial ratios that showcase AllovirInc's ability to generate income relative to its revenue or operating costs. If, let's say, AllovirInc is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, AllovirInc's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of AllovirInc's profitability requires more research than a typical breakdown of AllovirInc's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
Last ReportedProjected for 2023
Return on Average Assets(0.67) (0.73) 
Return on Average Equity(0.81) (0.83) 
Return on Invested Capital(1.10) (1.19) 
Return on Sales(130.03) (133.45) 

Management Efficiency

The entity has return on total asset (ROA) of (0.3797) % which means that it has lost $0.3797 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (0.7502) %, meaning that it created substantial loss on money invested by shareholders. AllovirInc management efficiency ratios could be used to measure how well allovirinc manages its routine affairs as well as how well it operates its assets and liabilities. As of 03/27/2023, Return on Average Assets is likely to drop to -0.73. In addition to that, Return on Average Equity is likely to drop to -0.83. AllovirInc Current Assets are relatively stable at the moment as compared to the past year. AllovirInc reported last year Current Assets of 243.05 Million. As of 03/27/2023, Tangible Assets Book Value per Share is likely to grow to 3.71, while Assets Non Current are likely to drop slightly above 28.2 M.
Last ReportedProjected for 2023
Book Value per Share 2.93  3.16 
Enterprise Value over EBIT(2.00) (2.16) 
Enterprise Value over EBITDA(2.25) (2.43) 
Price to Book Value 2.13  2.94 
Tangible Assets Book Value per Share 3.62  3.71 
Enterprise Value374.9 M384.8 M
Tangible Asset Value277.1 M273.1 M
The analysis of AllovirInc's management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze AllovirInc's future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of AllovirInc Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Non Current Liabilities Total
28.2 M
Short Long Term Debt Total
35.4 M
Total Operating Expenses
171.2 M
Common Stock Total Equity

Technical Drivers

As of the 27th of March, AllovirInc shows the risk adjusted performance of (0.07), and Mean Deviation of 3.89. AllovirInc technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to interpolate and analyze data for nineteen technical drivers for AllovirInc, which can be compared to its rivals. Please confirm AllovirInc downside deviation, treynor ratio, as well as the relationship between the Treynor Ratio and expected short fall to decide if AllovirInc is priced correctly, providing market reflects its regular price of 4.21 per share. Given that AllovirInc has jensen alpha of (0.38), we suggest you to validate AllovirInc's prevailing market performance to make sure the company can sustain itself at a future point.

AllovirInc Price Movement Analysis

null. The output start index for this execution was zero with a total number of output elements of zero. The Triple Exponential Moving Average (T3) indicator is developed by Tim Tillson as AllovirInc price series composite of a single exponential moving average, a double exponential moving average and a triple exponential moving average.

AllovirInc Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific AllovirInc insiders, such as employees or executives, is commonly permitted as long as it does not rely on AllovirInc's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases AllovirInc insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Van Beek Jeroen B over three months ago
Sale by Van Beek Jeroen B of 16074 shares of AllovirInc
Van Beek Jeroen B over three months ago
Sale by Van Beek Jeroen B of 36592 shares of AllovirInc
Van Beek Jeroen B over three months ago
Sale by Van Beek Jeroen B of 299 shares of Allovir
Van Beek Jeroen B over three months ago
Sale by Van Beek Jeroen B of 1070 shares of Allovir
Van Beek Jeroen B over three months ago
Sale by Van Beek Jeroen B of 1070 shares of Allovir
Hallal David over three months ago
Allovir exotic insider transaction detected
Van Beek Jeroen B over six months ago
Sale by Van Beek Jeroen B of 493 shares of Allovir
Brainard Diana over six months ago
Sale by Brainard Diana of 4564 shares of Allovir
Brainard Diana over six months ago
Acquisition by Brainard Diana of 100000 shares of Allovir subject to Rule 16b-3
F2 Mg Ltd over six months ago
Allovir exotic insider transaction detected
Elevatebio Llc over six months ago
Acquisition by Elevatebio Llc of 3253796 shares of Allovir subject to Rule 16b-3
Atillasoy Ercem over six months ago
Sale by Atillasoy Ercem of 1533 shares of Allovir

AllovirInc Predictive Daily Indicators

AllovirInc intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of AllovirInc stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

AllovirInc Forecast Models

AllovirInc time-series forecasting models is one of many AllovirInc's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary AllovirInc's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About AllovirInc Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how AllovirInc prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling AllovirInc shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual Stock such as AllovirInc. By using and applying AllovirInc Stock analysis, traders can create a robust methodology for identifying AllovirInc entry and exit points for their positions.
Last ReportedProjected for 2023
EBITDA Margin(1.93) (2.08) 
Gross Margin 0.90  0.89 
Profit Margin(6.47) (6.98) 

Current AllovirInc Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. AllovirInc analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. AllovirInc analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
21.25Strong Buy4Odds
AllovirInc current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most AllovirInc analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand AllovirInc stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of AllovirInc, talking to its executives and customers, or listening to AllovirInc conference calls.
AllovirInc Analyst Advice Details

AllovirInc Stock Analysis Indicators

AllovirInc stock analysis indicators help investors evaluate how AllovirInc stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading AllovirInc shares will generate the highest return on investment. By understating and applying AllovirInc stock analysis, traders can identify AllovirInc position entry and exit signals to maximize returns.
Begin Period Cash Flow202.5 M
Common Stock Shares Outstanding76.7 M
Total Stockholder Equity224.5 M
Total Cashflows From Investing Activities-80.5 M
Tax Provision-265 K
Property Plant And Equipment Net32.6 M
Retained Earnings-465.8 M
Cash And Short Term Investments233.8 M
Retained Earnings Total Equity-465.8 M
Cash106.1 M
Accounts PayableM
Net Debt-70.7 M
50 Day M A5.7241
Total Current Liabilities24.3 M
Non Current Assets Total34 M
Common Stock Total Equity9000.00
Non Currrent Assets Other1.5 M
Stock Based Compensation41.3 M
Check out Trending Equities. To learn how to invest in AllovirInc Stock please use our How to Invest in AllovirInc guide. You can also try Price Transformation module to use Price Transformation models to analyze depth of different equity instruments across global markets.

Complementary Tools for analysis

When running AllovirInc price analysis, check to measure AllovirInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AllovirInc is operating at the current time. Most of AllovirInc's value examination focuses on studying past and present price action to predict the probability of AllovirInc's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move AllovirInc's price. Additionally, you may evaluate how the addition of AllovirInc to your portfolios can decrease your overall portfolio volatility.
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Money Managers
Screen money managers from public funds and ETFs managed around the world
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Is AllovirInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AllovirInc. If investors know AllovirInc will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AllovirInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
Return On Assets
Return On Equity
The market value of AllovirInc is measured differently than its book value, which is the value of AllovirInc that is recorded on the company's balance sheet. Investors also form their own opinion of AllovirInc's value that differs from its market value or its book value, called intrinsic value, which is AllovirInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AllovirInc's market value can be influenced by many factors that don't directly affect AllovirInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AllovirInc's value and its price as these two are different measures arrived at by different means. Investors typically determine AllovirInc value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AllovirInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.